smithkline beecham overseas limited
smithkline beecham overseas limited Company Information
Company Number
02552828
Next Accounts
Sep 2025
Shareholders
smithkline beecham ltd
Group Structure
View All
Industry
Activities of head offices
Registered Address
79 new oxford street, london, WC1A 1DG
Website
http://gsk.comsmithkline beecham overseas limited Estimated Valuation
Pomanda estimates the enterprise value of SMITHKLINE BEECHAM OVERSEAS LIMITED at £0 based on a Turnover of £0 and 0.49x industry multiple (adjusted for size and gross margin).
smithkline beecham overseas limited Estimated Valuation
Pomanda estimates the enterprise value of SMITHKLINE BEECHAM OVERSEAS LIMITED at £0 based on an EBITDA of £-9k and a 3.89x industry multiple (adjusted for size and gross margin).
smithkline beecham overseas limited Estimated Valuation
Pomanda estimates the enterprise value of SMITHKLINE BEECHAM OVERSEAS LIMITED at £85.8m based on Net Assets of £40.7m and 2.11x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Smithkline Beecham Overseas Limited Overview
Smithkline Beecham Overseas Limited is a live company located in london, WC1A 1DG with a Companies House number of 02552828. It operates in the activities of head offices sector, SIC Code 70100. Founded in October 1990, it's largest shareholder is smithkline beecham ltd with a 100% stake. Smithkline Beecham Overseas Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Smithkline Beecham Overseas Limited Health Check
Pomanda's financial health check has awarded Smithkline Beecham Overseas Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 1 areas for improvement. Company Health Check FAQs
1 Strong
0 Regular
1 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Smithkline Beecham Overseas Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Smithkline Beecham Overseas Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Smithkline Beecham Overseas Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Smithkline Beecham Overseas Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (110)
- Smithkline Beecham Overseas Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Smithkline Beecham Overseas Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Smithkline Beecham Overseas Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Smithkline Beecham Overseas Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Smithkline Beecham Overseas Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Smithkline Beecham Overseas Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Smithkline Beecham Overseas Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1%, this is a lower level of debt than the average (55.6%)
- - Smithkline Beecham Overseas Limited
- - Industry AVG
SMITHKLINE BEECHAM OVERSEAS LIMITED financials
Smithkline Beecham Overseas Limited's latest turnover from December 2023 is 0 and the company has net assets of £40.7 million. According to their latest financial statements, we estimate that Smithkline Beecham Overseas Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | 46,498,000 | -78,248,000 | -17,178,000 | ||||||||||||
| Operating Profit | -9,000 | -3,000 | -11,000 | -3,106,000 | 1,384,000 | -46,498,000 | 78,248,000 | 17,178,000 | -12,000 | -9,000 | -8,000 | -8,000 | -14,000 | ||
| Interest Payable | 475,000 | 6,922,000 | 26,821,000 | ||||||||||||
| Interest Receivable | 1,832,000 | 508,000 | 1,000 | 41,000 | 3,702,000 | 4,846,000 | 1,899,000 | 13,000 | 7,000 | 9,000 | |||||
| Pre-Tax Profit | 1,823,000 | 505,000 | -10,000 | 26,000 | -3,106,000 | 1,384,000 | -46,498,000 | 78,248,000 | 16,716,000 | -5,000 | -8,000 | -8,000 | 5,709,965,000 | 1,983,244,000 | |
| Tax | -426,000 | -96,000 | 589,000 | -265,000 | 8,951,000 | -15,650,000 | -3,384,000 | 1,000 | 2,000 | 2,000 | 2,312,000 | 5,744,000 | |||
| Profit After Tax | 1,397,000 | 409,000 | -10,000 | 26,000 | -2,517,000 | 1,119,000 | -37,547,000 | 62,598,000 | 13,332,000 | -4,000 | -6,000 | -6,000 | 5,712,277,000 | 1,988,988,000 | |
| Dividends Paid | 13,234,457,000 | ||||||||||||||
| Retained Profit | 1,397,000 | 409,000 | -10,000 | 26,000 | -2,517,000 | 1,119,000 | -37,547,000 | 62,598,000 | 13,332,000 | -4,000 | -6,000 | -6,000 | -7,522,180,000 | 1,988,988,000 | |
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* | -9,000 | -3,000 | -11,000 | -3,106,000 | 1,384,000 | -46,498,000 | 78,248,000 | 17,178,000 | -12,000 | -9,000 | -8,000 | -8,000 | -14,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | 8,609,888,000 | ||||||||||||||
| Debtors (Due After 1 year) | 2,000 | 2,000 | 1,938,000 | ||||||||||||
| Total Fixed Assets | 2,000 | 2,000 | 1,938,000 | 8,609,888,000 | |||||||||||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | |||||||||||||||
| Group Debtors | 41,168,000 | 39,439,000 | 38,941,000 | 38,951,000 | 38,348,000 | 41,678,000 | 56,486,000 | 85,862,000 | 11,293,000 | 1,941,000 | 1,946,000 | 2,588,000 | 1,950,000 | 11,000 | 91,802,000 |
| Misc Debtors | 590,000 | 1,000 | 1,000 | ||||||||||||
| Cash | |||||||||||||||
| misc current assets | 1,829,000 | 11,016,000 | 7,364,000 | ||||||||||||
| total current assets | 41,168,000 | 39,439,000 | 38,941,000 | 38,951,000 | 38,938,000 | 43,507,000 | 56,486,000 | 96,878,000 | 18,657,000 | 1,942,000 | 1,946,000 | 2,588,000 | 1,950,000 | 11,000 | 91,803,000 |
| total assets | 41,168,000 | 39,439,000 | 38,941,000 | 38,951,000 | 38,938,000 | 43,507,000 | 56,486,000 | 96,878,000 | 18,657,000 | 1,942,000 | 1,946,000 | 2,590,000 | 1,952,000 | 1,949,000 | 8,701,691,000 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | |||||||||||||||
| Group/Directors Accounts | 7,000 | 7,000 | 20,000 | 1,809,000 | 15,662,000 | 3,365,000 | 8,000 | 9,000 | 9,000 | 653,000 | 9,000 | 1,173,707,000 | |||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 428,000 | 96,000 | 263,000 | 15,650,000 | 3,384,000 | 3,855,000 | |||||||||
| total current liabilities | 428,000 | 96,000 | 7,000 | 7,000 | 20,000 | 2,072,000 | 15,662,000 | 19,015,000 | 3,392,000 | 9,000 | 9,000 | 653,000 | 9,000 | 1,177,562,000 | |
| loans | 508,000 | ||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | 508,000 | ||||||||||||||
| total liabilities | 428,000 | 96,000 | 7,000 | 7,000 | 20,000 | 2,072,000 | 16,170,000 | 19,015,000 | 3,392,000 | 9,000 | 9,000 | 653,000 | 9,000 | 1,177,562,000 | |
| net assets | 40,740,000 | 39,343,000 | 38,934,000 | 38,944,000 | 38,918,000 | 41,435,000 | 40,316,000 | 77,863,000 | 15,265,000 | 1,933,000 | 1,937,000 | 1,937,000 | 1,943,000 | 1,949,000 | 7,524,129,000 |
| total shareholders funds | 40,740,000 | 39,343,000 | 38,934,000 | 38,944,000 | 38,918,000 | 41,435,000 | 40,316,000 | 77,863,000 | 15,265,000 | 1,933,000 | 1,937,000 | 1,937,000 | 1,943,000 | 1,949,000 | 7,524,129,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -9,000 | -3,000 | -11,000 | -3,106,000 | 1,384,000 | -46,498,000 | 78,248,000 | 17,178,000 | -12,000 | -9,000 | -8,000 | -8,000 | -14,000 | ||
| Depreciation | |||||||||||||||
| Amortisation | |||||||||||||||
| Tax | -426,000 | -96,000 | 589,000 | -265,000 | 8,951,000 | -15,650,000 | -3,384,000 | 1,000 | 2,000 | 2,000 | 2,312,000 | 5,744,000 | |||
| Stock | |||||||||||||||
| Debtors | 1,729,000 | 498,000 | -10,000 | 13,000 | -2,740,000 | -14,808,000 | -29,376,000 | 74,569,000 | 9,351,000 | -4,000 | -644,000 | 638,000 | 3,000 | -89,854,000 | 91,803,000 |
| Creditors | |||||||||||||||
| Accruals and Deferred Income | 332,000 | 96,000 | -263,000 | 263,000 | -15,650,000 | 12,266,000 | 3,384,000 | -3,855,000 | 3,855,000 | ||||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | -1,832,000 | -501,000 | -1,000 | -40,000 | 16,190,000 | -23,821,000 | 295,000 | 7,827,000 | -7,000 | 635,000 | -644,000 | -9,000 | 88,311,000 | -82,218,000 | |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | -8,609,888,000 | 8,609,888,000 | |||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -7,000 | -13,000 | -1,789,000 | -13,853,000 | 12,297,000 | 3,357,000 | -1,000 | -644,000 | 644,000 | 9,000 | -1,173,707,000 | 1,173,707,000 | |||
| Other Short Term Loans | |||||||||||||||
| Long term loans | -508,000 | 508,000 | |||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 1,832,000 | 508,000 | 1,000 | 41,000 | 3,702,000 | 4,846,000 | 1,899,000 | -462,000 | 7,000 | 9,000 | -6,922,000 | -26,821,000 | |||
| cash flow from financing | 1,832,000 | 501,000 | 1,000 | 28,000 | -1,789,000 | -10,659,000 | 17,651,000 | 5,256,000 | -463,000 | 7,000 | -635,000 | 644,000 | 9,000 | -1,180,629,000 | 6,682,027,000 |
| cash and cash equivalents | |||||||||||||||
| cash | |||||||||||||||
| overdraft | |||||||||||||||
| change in cash |
smithkline beecham overseas limited Credit Report and Business Information
Smithkline Beecham Overseas Limited Competitor Analysis
Perform a competitor analysis for smithkline beecham overseas limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mature companies, companies in WC1A area or any other competitors across 12 key performance metrics.
smithkline beecham overseas limited Ownership
SMITHKLINE BEECHAM OVERSEAS LIMITED group structure
Smithkline Beecham Overseas Limited has no subsidiary companies.
Ultimate parent company
2 parents
SMITHKLINE BEECHAM OVERSEAS LIMITED
02552828
smithkline beecham overseas limited directors
Smithkline Beecham Overseas Limited currently has 3 directors. The longest serving directors include Mrs Ciara Lynch (Mar 2020) and Mrs Laura Guittard (Jan 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Ciara Lynch | England | 56 years | Mar 2020 | - | Director |
| Mrs Laura Guittard | United Kingdom | 59 years | Jan 2022 | - | Director |
| Mrs Laura Guittard | United Kingdom | 59 years | Jan 2022 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
-9k
+200%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
40.7m
+0.04%
total assets
41.2m
+0.04%
cash
0
0%
net assets
Total assets minus all liabilities
smithkline beecham overseas limited company details
company number
02552828
Type
Private limited with Share Capital
industry
70100 - Activities of head offices
incorporation date
October 1990
age
35
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
December 2023
previous names
noblefuture limited (November 1990)
accountant
-
auditor
-
address
79 new oxford street, london, WC1A 1DG
Bank
-
Legal Advisor
-
smithkline beecham overseas limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to smithkline beecham overseas limited.
smithkline beecham overseas limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SMITHKLINE BEECHAM OVERSEAS LIMITED. This can take several minutes, an email will notify you when this has completed.
smithkline beecham overseas limited Companies House Filings - See Documents
| date | description | view/download |
|---|
